Welcome

TARGET is a multi-center, randomized clinical trial aimed at understanding how different treatments for rheumatoid arthritis (RA) affect cardiac inflammation. We hope that the results of this trial will improve cardiac outcomes in patients with RA by bringing to light if and how RA medications influence heart health.

Interested Patients

Eligible patients have rheumatoid arthritis and have taken methotrexate for 3 months . 

Interested Researchers

See below if you're interested in becoming a TARGET study site or conducting an ancillary study. 

Interested Physicians

See below for more information about the trial if you're interested in referring patients to TARGET. 

Participating Study Sites

If you're already a member of the TARGET team, see below for training, IRB, or Lab information. Contact your site coordinator or Kathleen at kvanni@bwh.harvard.edu for the site password.